Pharma CEO jacks drug price 400%, citing “moral requirement to make money”

The chief executive of a small pharmaceutical company defended hiking the price of an essential antibiotic by more than 400 percent and told the Financial Times that he thinks “it is a moral requirement to make money when you can.

Read More

Image courtesy of: Beth Mole